Rituximab combined with intravenous immunoglobulin in autoimmune diseases: a systematic review
Abstract Background Although using Rituximab (RTX) and intravenous immunoglobulin (IVIg) alone or sequentially is a well-established treatment for several autoimmune diseases, the combination of these two forms of therapy is still rare, and its use is poorly studied. Aim To perform a systematic revi...
| Published in: | Advances in Rheumatology |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s42358-025-00450-x |